About Diaceutics
Diaceutics is a company based in Belfast (United Kingdom) founded in 2005. The company has 199 employees as of December 31, 2024. Diaceutics offers products and services including DXRX Network, DXRX Data Solutions, and DXRX Signal. Diaceutics operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter Belfast, United Kingdom
- Employees 199 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Diaceutics Plc
-
Annual Revenue
$40.29 M (USD)35.69as on Dec 31, 2024
-
Net Profit
-$2.13 M (USD)2.46as on Dec 31, 2024
-
EBITDA
$2.92 M (USD)13.38as on Dec 31, 2024
-
Latest Funding Round
$26.14 M (USD), Post-IPO
Jun 11, 2020
-
Investors
SVB
& 1 more
-
Employee Count
199
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Diaceutics
Diaceutics is a publicly listed company on the LSE with ticker symbol DXRX in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Diaceutics
Diaceutics offers a comprehensive portfolio of products and services, including DXRX Network, DXRX Data Solutions, and DXRX Signal.
Facilitates collaboration for precision medicine stakeholders.
Provides access to real-world diagnostic testing data pipelines.
Links rare disease patients to targeted therapies efficiently.
People of Diaceutics
Unlock access to complete
Unlock access to complete
Funding Insights of Diaceutics
Investors in Diaceutics
Diaceutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB and Whiterock Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funding is provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Banking services are provided to innovative companies, investors, and individuals.
|
Locked | Locked | Locked |
Investor details for Diaceutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diaceutics
Investment portfolio details for Diaceutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diaceutics
Detailed financials for Diaceutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diaceutics Comparisons
Peer comparison for Diaceutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diaceutics
Diaceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Diaceutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diaceutics
Complete news archive for Diaceutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diaceutics
Diaceutics was founded in 2005 and raised its 1st funding round 13 years after it was founded.
Diaceutics is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
As of Dec 31, 2024, the latest employee count at Diaceutics is 199.
Annual revenue of Diaceutics is $40.29M as on Dec 31, 2024.
Diaceutics Group acts as an integrator in the precision medicine space. The company uses analytics, software, services and consulting to enable integration of therapies and diagnostics into the treatment pathway. The companys services include strategic consulting; digital decision tools and training; laboratory test commercialization; and branding and communication of personalized medicine solutions. The Groups divisions include: Labceutics, Diaceutics AIS, Lceltics, and Bioceutics. It client list includes Novartis, Pfizer, Boehringer Ingelheim, MedImmune, AstraZeneca and Bristol Myers-Squibb, the Bill Melinda Gates Foundation and many more.
Diaceutics's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Diaceutics offers DXRX Network, DXRX Data Solutions, and DXRX Signal.
Yes, Diaceutics is publicly traded on LSE under the ticker symbol DXRX.
Diaceutics has 2 investors. Key investors include SVB, and Whiterock Finance.
The ticker symbol of Diaceutics is DXRX on LSE.